MedPath

Early Intensive Hand Rehabilitation After Spinal Cord Injury

Phase 3
Completed
Conditions
Spinal Cord Injury
Interventions
Device: ReJoyce Workstation
Other: Standard Care
Registration Number
NCT01086930
Lead Sponsor
University of Melbourne
Brief Summary

Loss of hand function is one of the most devastating consequences of tetraplegia because of the severe impact on activities of daily living (ADL) and the resultant dependency on others. This multi-centre study in 78 participants will measure whether additional hand therapy provided via an electrical stimulator glove and specialised computer workstation improves hand function in people with tetraplegia.

Detailed Description

The study is a multi-centre, assessor-blind, randomised controlled phase III trial in patients with tetraplegia (a spinal cord injury). A total of 78 participants will be randomised into two groups; 1. the experimental group and 2. the control group. The control group will receive their standard rehabilitation care, while the experimental group will receive the standard rehabilitation care plus the study treatment. The study treatment will consist of one hour of extra hand training, 5 times a week, using a specialised glove which provides electrical impulses to the patient's hand allowing them to open and close their hand. The glove will be used to play games on a specialised computer workstation which focuses on hand movement and function.

The main objective of this study is to determine if the experimental treatment is more effective than standard rehabilitation care alone in participants with tetraplegia.

Total study duration is 3 years, including an 18 month recruitment period, an 8-week treatment period followed by 6 month and 12 month follow up assessments.

The progress of the participant's therapy during the study will be assessed by a blinded assessor (the assessor will not know which group the participants are in) using standard physiotherapy and occupational therapy assessments which focus on hand function. These involve grasping and releasing different everyday objects and performing everyday tasks as well as quality of life questionnaires.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients will be included if they:

  1. have sustained a SCI within the preceding 6 months from time of consent
  2. are currently receiving inpatient rehabilitation through one of the study sites
  3. will remain in hospital for 12 weeks after initial screening as part of their standard medical/rehabilitation care
  4. are 16 years of age or older and able to provide informed consent
  5. have a motor complete or incomplete spinal cord injury at the neurological level of C2 to T1 (as per the International Standardised Neurological Assessment for SCI)
  6. can actively flex their shoulder/s to 60 degrees
  7. have reduced ability to grasp using their hands
  8. are able to tolerate sufficient FES to enable one hand to grasp and release
  9. have the potential to benefit from FES and ReJoyce according to the judgment of the treating therapist
Exclusion Criteria

Patients will not be included if they:

  1. have any other type of neurological injury affecting the target hand (e.g. brachial plexus or peripheral nerve injuries)
  2. have had recent trauma or surgery to the target hand or upper limb within the last 12 months
  3. have had amputation of any digits on the target hand
  4. are not able to sit out of bed each day for at least 2 hours over three consecutive days
  5. have extensive fixed contractures in the upper limb of the target hand preventing use of the ReJoyce
  6. have severe spasticity in the target hand or upper limb preventing use of the ReJoyce
  7. are unable to attend the 6-month and 1-year follow-up assessments at their treating spinal unit
  8. are likely to undergo hand surgery in the target hand in the next year
  9. might experience autonomic dysreflexia and/or hypotension in response to electrical stimulation
  10. have any contraindications to FES, such as cardiac pacemaker, epilepsy, forearm fracture or pregnancy
  11. have intracranial metal implants
  12. have impaired vision and/or are unable to view a computer screen
  13. have any other serious medical condition including malignancies, psychiatric, behavioural or drug-dependency problems, which are likely to influence the participant's ability to cooperate or in the opinion of the study investigator would prevent the participant from adhering to the Protocol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupStandard CareIn addition to standard care participants in Group A will receive: • One hour of extra hand training five times per week for 8 weeks using the ReJoyce Workstation. The training will be supervised by a therapist and provided to the target hand. The hand exercises will be incorporated into computer games and will involve the following tasks using different manipulanda: * reaching * grasping * manipulating * pulling * rotating * releasing
Standard Care GroupStandard CareParticipants in the control group will not receive any training on the instrumented workstation or electrical stimulation to the hand or upper limb. They will however continue to receive standard care as well as three 15-minute specific hand activity sessions per week specifically devoted to the practice of hand activities in a one-to-one format with a therapist (as per the treatment received by the experimental group).
Intervention GroupReJoyce WorkstationIn addition to standard care participants in Group A will receive: • One hour of extra hand training five times per week for 8 weeks using the ReJoyce Workstation. The training will be supervised by a therapist and provided to the target hand. The hand exercises will be incorporated into computer games and will involve the following tasks using different manipulanda: * reaching * grasping * manipulating * pulling * rotating * releasing
Primary Outcome Measures
NameTimeMethod
Modified Action Research Arm Test8 weeks and 26 weeks

A standardized measure of unilateral hand and upper limb function

Secondary Outcome Measures
NameTimeMethod
Summed Upper Limb Strength of the Graded and Redefined Assessment of Strength Sensibility and Prehension8 weeks and 26 weeks

Summed strength score of 10 upper limb muscles

Capabilities of Upper Extremity8 weeks and 26 weeks

A questionnaire about upper limb function

Assessment of Quality of Life (AQoL)8 weeks and 26 weeks

A questionnaire to assess quality of life

Self-care subscale of the Spinal Cord Independence Measure8 weeks and 24 weeks

A questionnaire about independence in self-care

Goal Attainment Scale8 weeks

An assessment of whether a participant achieved pre-set goals

Participant Perception of Treatment Effectiveness8 weeks

Self resport of treatment effectiveness

Sensory Score on ISNCSCI8 weeks and 26 weeks

Scores for light touch and pinprick tested in dermatomes of the upper limb

Health Utilities Index Mark 38 weeks and 24 weeks

A questionnaire to assess quality of life, but includes a domain on hand function

AsTex Sensory Test8 weeks and 26 weeks

A measure of texture discrimination in the fingertips

AuSpinal Test8 weeks and 26 weeks

A test of hand function

Trial Locations

Locations (7)

Royal Rehabilitation Centre Sydney

🇦🇺

Sydney, New South Wales, Australia

Sir George Bebrook Spinal Injuries Centre, Royal Perth Hospital

🇦🇺

Shenton Park, Western Australia, Australia

Spinal Unit, Prince of Wales Hospital

🇦🇺

Randwick, New South Wales, Australia

Queensland Spinal Cord Injury Service, Princess Alexandra Hospital

🇦🇺

Woolloongabba, Queensland, Australia

South Australian Spinal Cord Injury Service, Hampstead Rehabilitation Centre

🇦🇺

Northfield, South Australia, Australia

Victorian Spinal Cord Injury Service, Royal Talbot Rehabilitation Centre

🇦🇺

Kew, Victoria, Australia

Burwood Academy

🇳🇿

Christchurch, New Zealand

© Copyright 2025. All Rights Reserved by MedPath